AIDS-related primary brain lymphomas: Histopathologic and immunohistochemical study of 51 cases

被引:77
作者
CamilleriBroet, S
Davi, F
Feuillard, J
Seilhean, D
Michiels, JF
Brousset, P
Epardeau, B
Navratil, E
Mokhtari, K
Bourgeois, C
Marelle, L
Raphael, M
Hauw, JJ
机构
[1] CHU PITIE SALPETRIERE, LAB NEUROPATHOL R ESCOUROLLE,CNRS URA 625, SERV HEMATOL,INSERM U360, PARIS, FRANCE
[2] HOP AVICENNE, SERV HEMATOL BIOL, F-93009 BOBIGNY, FRANCE
[3] HOP BEAUJON, SERV ANAT PATHOL, CLICHY, FRANCE
[4] HOP PURPAN, TOULON, FRANCE
[5] HOP LOUIS PASTEUR, F-06002 NICE, FRANCE
[6] HOP FOCH, SURESNES, FRANCE
关键词
primary brain lymphoma; acquired immunodeficiency syndrome; Epstein-Barr virus; bcl-2;
D O I
10.1016/S0046-8177(97)90137-4
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Fifty-one cases of acquired immunodeficiency syndrome (AIDS)-related primary brain lymphomas (AR-PBL) ere investigated for clinical characteristics; human immunodeficiency virus (HIV)-associated disorders; histopathologic features; immunophenotype; Epstein-Barr virus (EBV) infection; and, when frozen tissue was available, oncogene rearrangements. AR-PBL occurred late in the course of AIDS and were usually associated with other systemic or cerebral disorders and with a low level of CD4 lymphocytes. All cases were high grade lymphomas according to the Working Formulation or updated Kiel classification, and often displayed a multifocal pattern. Thirty cases were classified as immunoblastic with plasmacytic differentiation, 18 cases were large cell lymphomas with an immunoblastic component or centroblastic polymorphic lymphomas, and 2 were small noncleaved non-Burkitt lymphomas (Working Formulation). This latter category is classified as Burkitt's-like lymphoma in the REAL nomenclature. One case could not be classified because of necrosis. AR-PBL showed a high level expression of activation and adhesion molecules. The presence of EBV was detected in most cases, and, when PCR was used, this was a constant finding. bcl-2 oncoprotein and latent membrane protein-1 (LMP-1) were strongly expressed. None of the tested cases expressed p53, or were rearranged for bcl-2 or c-myc oncogenes. This study confirms the immunophenotypic specificity of AR-PEL, which may reflect the special immune status of the brain. Copyright (C) 1997 by W.B. Saunders Company.
引用
收藏
页码:367 / 374
页数:8
相关论文
共 45 条
[1]   OLIGONUCLEOTIDES FOR POLYMERASE CHAIN-REACTION AMPLIFICATION AND HYBRIDIZATION DETECTION OF EPSTEIN-BARR-VIRUS DNA IN CLINICAL SPECIMENS [J].
AMBINDER, RF ;
LAMBE, BC ;
MANN, RB ;
HAYWARD, SD ;
ZEHNBAUER, BA ;
BURNS, WS ;
CHARACHE, P .
MOLECULAR AND CELLULAR PROBES, 1990, 4 (05) :397-407
[2]  
ANDERS KH, 1986, AM J PATHOL, V124, P537
[3]   PRIMARY CENTRAL-NERVOUS-SYSTEM MALIGNANT NON-HODGKINS-LYMPHOMAS FROM HIV-INFECTED AND NONINFECTED PATIENTS - EXPRESSION OF CELLULAR-SURFACE PROTEINS AND EPSTEIN-BARR VIRAL MARKERS [J].
AUPERIN, I ;
MIKOL, J ;
OKSENHENDLER, E ;
THIEBAUT, JB ;
BRUNET, M ;
DUPONT, B ;
MORINET, F .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1994, 20 (03) :243-252
[4]   DETECTION OF EPSTEIN-BARR VIRUS IN CNS LYMPHOMAS BY INSITU HYBRIDIZATION [J].
BASHIR, RM ;
HARRIS, NL ;
HOCHBERG, FH ;
SINGER, RM .
NEUROLOGY, 1989, 39 (06) :813-817
[5]   AIDS-ASSOCIATED NON-HODGKIN LYMPHOMA [J].
BERAL, V ;
PETERMAN, T ;
BERKELMAN, R ;
JAFFE, H .
LANCET, 1991, 337 (8745) :805-809
[6]   HIGH EXPRESSION OF LATENT MEMBRANE-PROTEIN-1 OF EPSTEIN-BARR-VIRUS AND BCL-2 ONCOPROTEIN IN ACQUIRED IMMUNODEFICIENCY SYNDROME-RELATED PRIMARY BRAIN LYMPHOMAS [J].
CAMILLERIBROET, S ;
DAVI, F ;
FEUILLARD, J ;
BOURGEOIS, C ;
SEILHEAN, D ;
HAUW, JJ ;
RAPHAEL, M .
BLOOD, 1995, 86 (02) :432-435
[7]   THE IMPACT OF EBV, PROLIFERATION RATE, AND BCL-2 EXPRESSION IN HODGKINS-DISEASE IN CHILDHOOD [J].
CLAVIEZ, A ;
TIEMANN, M ;
PETERS, J ;
KREIPE, H ;
SCHNEPPENHEIM, R ;
PARWARESCH, R .
ANNALS OF HEMATOLOGY, 1994, 68 (02) :61-66
[8]   EPSTEIN-BARR VIRUS NUCLEAR PROTEIN-2 IS A KEY DETERMINANT OF LYMPHOCYTE-TRANSFORMATION [J].
COHEN, JI ;
WANG, F ;
MANNICK, J ;
KIEFF, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (23) :9558-9562
[9]  
DEGIROLAMI U, 1990, ARCH PATHOL LAB MED, V114, P643
[10]  
DELECLUSE HJ, 1993, BLOOD, V82, P552